119 related articles for article (PubMed ID: 11724302)
1. FHIT RNA and protein expression in oral squamous cell carcinomas.
van Heerden WF; Swart TJ; Robson B; Smith TL; Engelbrecht S; van Heerden MB; van Rensburg EJ; Huebner K
Anticancer Res; 2001; 21(4A):2425-8. PubMed ID: 11724302
[TBL] [Abstract][Full Text] [Related]
2. Multiple molecular alterations of FHIT in betel-associated oral carcinoma.
Chang KW; Kao SY; Tzeng RJ; Liu CJ; Cheng AJ; Yang SC; Wong YK; Lin SC
J Pathol; 2002 Mar; 196(3):300-6. PubMed ID: 11857493
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL
Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317
[TBL] [Abstract][Full Text] [Related]
4. Fhit protein expression in oral epithelium: immunohistochemical evaluation of three antisera.
van Heerden WF; Swart TJ; van Heerden MB; Pekarsky Y; Sutherland R; Huebner K
Anticancer Res; 2001; 21(4A):2419-23. PubMed ID: 11724301
[TBL] [Abstract][Full Text] [Related]
5. [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma].
Liu FX; Huang XP; Zhao CX; Xu X; Han YL; Cai Y; Wu RL; Wu M; Zhan QM; Wang MR
Ai Zheng; 2004 Sep; 23(9):992-8. PubMed ID: 15363189
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of the FHIT gene in human oral carcinogenesis.
Tanimoto K; Hayashi S; Tsuchiya E; Tokuchi Y; Kobayashi Y; Yoshiga K; Okui T; Kobayashi M; Ichikawa T
Br J Cancer; 2000 Feb; 82(4):838-43. PubMed ID: 10732756
[TBL] [Abstract][Full Text] [Related]
7. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
8. [HPV detection and FHIT expression in esophageal squamous carcinoma from high incidence area in Cixian County].
Liu YL; Li XM; Jin GL; Yan X; Yang JZ; Wang JL; Li YH; Wang FR; Zhang XH
Ai Zheng; 2003 May; 22(5):492-5. PubMed ID: 12753709
[TBL] [Abstract][Full Text] [Related]
9. Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses.
Macabeo-Ong M; Ginzinger DG; Dekker N; McMillan A; Regezi JA; Wong DT; Jordan RC
Mod Pathol; 2002 Sep; 15(9):979-87. PubMed ID: 12218216
[TBL] [Abstract][Full Text] [Related]
10. [Expression and significance of fragile histidine triad in oral cancer and precancerous lesions].
Yin C; Shen LJ; Xie SM; Ruan P; Yao X
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):584-6. PubMed ID: 15897145
[TBL] [Abstract][Full Text] [Related]
11. Loss of Fhit protein expression in high-grade and advanced stage endometrial carcinomas.
Yura Y; Mandai M; Konishi I; Hamid AA; Tsuruta Y; Kusakari T; Fujii S
Anticancer Res; 2003; 23(3C):2837-43. PubMed ID: 12926121
[TBL] [Abstract][Full Text] [Related]
12. Analysis of FHIT allelic imbalance/loss of heterozygosity and FHIT expression in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Sep; 35(9):816-25. PubMed ID: 18494825
[TBL] [Abstract][Full Text] [Related]
13. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
14. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma.
Dos Reis PP; Bharadwaj RR; Machado J; Macmillan C; Pintilie M; Sukhai MA; Perez-Ordonez B; Gullane P; Irish J; Kamel-Reid S
Cancer; 2008 Dec; 113(11):3169-80. PubMed ID: 18991282
[TBL] [Abstract][Full Text] [Related]
15. Fragile histidine triad expression in oral squamous cell carcinoma and precursor lesions.
Kujan O; Oliver R; Roz L; Sozzi G; Ribeiro N; Woodwards R; Thakker N; Sloan P
Clin Cancer Res; 2006 Nov; 12(22):6723-9. PubMed ID: 17121892
[TBL] [Abstract][Full Text] [Related]
16. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
17. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer.
Tzao C; Tsai HY; Chen JT; Chen CY; Wang YC
Eur J Cancer; 2004 Sep; 40(14):2175-83. PubMed ID: 15341994
[TBL] [Abstract][Full Text] [Related]
18. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed genes in oral squamous cell carcinoma.
Arora S; Matta A; Shukla NK; Deo SV; Ralhan R
Mol Carcinog; 2005 Feb; 42(2):97-108. PubMed ID: 15599930
[TBL] [Abstract][Full Text] [Related]
20. Loss of Fhit expression is a predictor of poor outcome in tongue cancer.
Lee JI; Soria JC; Hassan K; Liu D; Tang X; El-Naggar A; Hong WK; Mao L
Cancer Res; 2001 Feb; 61(3):837-41. PubMed ID: 11221865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
